Multicenter, Double-blind, Placebo-controlled, Parallel-group, Phase IV Study to Assess the Effect of Rotigotine on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease.
Phase of Trial: Phase IV
Latest Information Update: 08 Mar 2017
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors UCB
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jun 2012 Planned End Date changed from 1 Feb 2013 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 21 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.